Your Best Stock
Stocks Biotechnology REGN

Regeneron Pharmaceuticals REGN

US equityMarket cap rank #199BiotechnologyInfectious Disease
$791.33
−$10.50 (-1.31%)
Market open · Sep 24, 1:10 pm ET
After hours $801.82 0.00%
Open$801.59
Prev close$801.82
Day range$789.41 – $807.21
Volume246.9K
Market cap$81.47B
P/E (TTM)19.6
Dividend yield0.46%

Analyst view

ConsensusBuy
Analysts19
Average target$841.37+6.3% vs. price
  • Buy 63%
  • Hold 37%
Low $700.00Now $791.33Avg $841.37High $1,030.00
ConsensusBuy
Analysts covering19
Price target (avg)$841.37
Target range$700.00 – $1,030.00
Buy / Hold / Sell63% / 37% / 0%

Recent rating changes

DateFirmRatingTarget
10 Sep 2026 HSBC BUY $920.00
17 Aug 2026 Leerink Partners HOLD $824.00
5 Aug 2026 Barclays BUY $917.00
4 Aug 2026 J.P. Morgan BUY $900.00
3 Aug 2026 Guggenheim BUY $1,030.00
31 Jul 2026 Wells Fargo HOLD $750.00
31 Jul 2026 Truist Financial BUY $772.00
31 Jul 2026 Baird HOLD $761.00
31 Jul 2026 Scotiabank HOLD $770.00
31 Jul 2026 Morgan Stanley HOLD $758.00
31 Jul 2026 BMO Capital BUY $800.00
31 Jul 2026 Barclays BUY $917.00
Scroll to Top